A study to test how well different doses of BI 1584862 are tolerated by healthy me
Phase 1
- Conditions
- Healthy volunteer trialMedDRA version: 20.0Level: SOCClassification code: 10015919Term: Eye disorders Class: 9Therapeutic area: Diseases [C] - Eye Diseases [C11]
- Registration Number
- CTIS2023-503541-54-00
- Lead Sponsor
- Boehringer Ingelheim International GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method